ZLE:CA:TSX-BMO Low Volatility Emerging Markets Equity ETF (CAD)

ETF | Emerging Markets Equity |

Last Closing

CAD 20.42

Change

+0.21 (+1.04)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Emerging Markets Equity

Symbol Name Price(Change) Market Cap
XSEM:CA iShares ESG MSCI Emerging Mark..

+0.42 (+1.90%)

CAD 3.24B
XEC:CA iShares Core MSCI Emerging Mar..

+0.42 (+1.38%)

CAD 1.92B
ZEM:CA BMO MSCI Emerging Markets Inde..

+0.30 (+1.30%)

CAD 1.12B
XEM:CA iShares MSCI Emerging Markets ..

+0.43 (+1.22%)

CAD 0.20B
DRFE:CA Desjardins RI Emerging Markets..

+0.27 (+1.13%)

CAD 0.08B
XMM:CA iShares MSCI Min Vol Emerging ..

+0.34 (+1.12%)

CAD 0.06B
RXD:CA RBC Quant Emerging Markets Div..

+0.33 (+1.51%)

CAD 0.05B
VEE:CA Vanguard FTSE Emerging Markets

+0.48 (+1.20%)

N/A

ETFs Containing ZLE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Emerging Markets Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.33% 44% F 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.33% 44% F 74% C
Trailing 12 Months  
Capital Gain 21.26% 22% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.26% 22% F 55% F
Trailing 5 Years  
Capital Gain -2.30% 11% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.30% 11% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike